PerkinElmer to Display Cancer Immunology Research Solutions at 2015 ASCO Annual Meeting

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it will showcase its cancer immunology research offerings at the 2015 American Society for Clinical Oncology (ASCO) Annual Meeting. “The ASCO event provides us with the opportunity to share our quantitative pathology instruments, staining kits and software with researchers committed to advancing cancer research,” said Brian Kim, President, Life Sciences & Technology, PerkinElmer. “Our cancer immunology platform enables scientists to see and measure the interactions between immune cells and cancer cells in the tumor microenvironments, helping them to anticipate responses to immunotherapy drugs.” WHEN: May 29-June 2, 2015 WHERE: McCormick Place, Chicago (Booth#22138) ON DISPLAY: PerkinElmer will showcase the following offerings at ASCO 2015: Mantra™ Quantitative Pathology Workstation with inForm® Advanced Image Analysis Software: designed to enable easy visualization, quantification and phenotyping of multiple types of immune cells in situ simultaneously in intact FFPE tissue sections, which can help research pathologists discover and develop biomarkers and protein expression in solid tumors. Opal™ Multiplex Staining Kits: provide specific staining of multiple tissue biomarkers in a single image to simultaneously interrogate multiple pathways, while retaining context provided by tissue images. TIBCO® Spotfire® Analyst for Quantitative Pathology: allows researchers to combine multivariate data from PerkinElmer’s image analysis software to visualize, analyze and determine trends. MORE: Follow us on Twitter @PKILifeScience and join the conversation around ASCO using #asco2015.